StonvexLoading…
StonvexStonvexStonvexCore line items from ACB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-03-31 | Annual 2022 2022-06-30 | Annual 2021 2021-06-30 | Annual 2020 2020-06-30 |
|---|---|---|---|---|
Revenue | C$174.97M | C$221.34M | C$245.25M | C$268.70M |
Operating Income | C$-147.11M | C$-231.45M | C$-282.82M | C$-465.78M |
Net Income | C$-205.14M | C$-1.72B | C$-695.09M | C$-3.31B |
EPS (Diluted) | C$-6.13 | C$-7.99 | C$-4.10 | Not available |
Total Assets | C$926.32M | C$1.08B | C$2.60B | C$2.78B |
Total Liabilities | C$404.62M | C$422.00M | C$567.03M | C$656.70M |
Cash & Equivalents | C$255.59M | C$437.81M | C$421.46M | C$162.18M |
Free Cash Flow OCF − CapEx | C$-127.94M | C$-142.48M | C$-263.66M | Not available |
Shares Outstanding | Not available | Not available | Not available | 21.01M |